The Association of Clinical Research Professionals

Webinar Replay—Session I: Continuing Organizational SOP Needs to Maintain Compliance


  • Edye Edens, JD, MA, CIP, CCRP, Senior Research Compliance Consultant, First Class Solutions

Pricing With Contact Hours

Member: $15 | Nonmember: $75

Add to Cart

This course is approved for 1.0 ACRP contact hours. Accreditation Details

Session Replay Expires February 4, 2024.

Pricing Without Contact Hours

Member: $0 | Nonmember: N/A

Add to Cart

This Webinar is part one of the two-part Webinar series Adaptive Operational Optimization through Transformative SOPs.

Take a deep dive into transforming operational effectiveness by utilizing three key areas in drafting your clinical research standard operating procedures (SOPs) so they are specific, meaningful, and productive for your unique research organization. By focusing on critical flexibilities in the current challenging environment, ongoing integration of heightened emotional intelligence, and core compliance mechanisms, session participants will polish their skill set to craft customized SOPs within their organizations.

This Webinar will define and enumerate the stages of the SOP life cycle beyond merely drafting to include training and enforcement as well. Presenters’ use of case study pedagogy will assist you in interactively drafting an SOP together to demonstrate the importance of flexibility, EQ, and compliance in the SOP life cycle.

Upon completion of this Webinar, attendees should be able to understand and identify:

  1. Exercise emotional quotient-based design thinking to appropriately draft SOPs that include all potential stakeholders
  2. Understand common blind spots within basic compliance mechanisms and employ programmatic compliance pillars to provide instant infrastructure to your SOP writing efforts
  3. Draft more adaptive SOPs with enough specificity that they are valuable reference tools and training materials, but also with enough flexibility that those SOPs can withstand the current challenging COVID research climate and better prepare your organization for new ways of conducting clinical trials